MURAL - Maynooth University Research Archive Library



    Patents, Governance and Control: Ethics and the Patentability of Novel Beings and Advanced Biotechnologies in Europe


    McMahon, Aisling (2021) Patents, Governance and Control: Ethics and the Patentability of Novel Beings and Advanced Biotechnologies in Europe. Cambridge Quarterly of Healthcare Ethics, 30 (3). pp. 529-542. ISSN 0963-1801

    [img]
    Preview
    Download (164kB) | Preview


    Share your research

    Twitter Facebook LinkedIn GooglePlus Email more...



    Add this article to your Mendeley library


    Abstract

    This article focuses primarily on to what extent novel beings, and particularly, beings which display something akin to human consciousness or agency would be (or should be) patentable under current European patent law. Patents grant the patent holder a right to exclude others from using the patented invention for the period of patent grant (usually 20 years). This allows the patent holder to control how that invention can or cannot be used by others downstream, granting patent holders a governance like function over the patented technology for the duration of the patent. Accordingly, the potential for patentability of novel beings gives rise to a myriad of ethical issues including: to what extent is it appropriate for patent holders to retain and exercise patents over “novel beings”; how issues of “agency” displayed by any “novel beings” would fit within the current patent framework, if at all; and to what extent existing exclusions from patentability might exclude patents on “novel beings” or whether changes within patent law may be needed if patents in relation to “novel beings” are deemed ethically problematic. This article focuses on such issues, and in doing so, also sheds light on the role of ethical issues within the patenting of advanced biotechnologies more generally

    Item Type: Article
    Additional Information: Cite as: McMahon, A. (2021). Patents, governance and control: Ethics and the patentability of novel beings and advanced biotechnologies in europe: CQ. Cambridge Quarterly of Healthcare Ethics, 30(3), 529-542. doi:https://doi.org/10.1017/S0963180120001073
    Keywords: Patents; Patent ethics; biotechnology; novel beings; morality provisions; European patent law;
    Academic Unit: Assisting Living & Learning,ALL institute
    Faculty of Social Sciences > Law
    Item ID: 16711
    Identification Number: https://doi.org/10.1017/S0963180120001073
    Depositing User: Aisling McMahon
    Date Deposited: 16 Nov 2022 11:50
    Journal or Publication Title: Cambridge Quarterly of Healthcare Ethics
    Publisher: Proquest
    Refereed: Yes
    URI:
    Use Licence: This item is available under a Creative Commons Attribution Non Commercial Share Alike Licence (CC BY-NC-SA). Details of this licence are available here

    Repository Staff Only(login required)

    View Item Item control page

    Downloads

    Downloads per month over past year

    Origin of downloads